GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kineta Inc (STU:J75) » Definitions » Additional Paid-In Capital

Kineta (STU:J75) Additional Paid-In Capital : €158.38 Mil(As of Jun. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Kineta Additional Paid-In Capital?


Kineta's quarterly additional paid-in capital increased from Dec. 2023 (€154.67 Mil) to Mar. 2024 (€156.05 Mil) and increased from Mar. 2024 (€156.05 Mil) to Jun. 2024 (€158.38 Mil).

Kineta's annual additional paid-in capital increased from Dec. 2021 (€67.38 Mil) to Dec. 2022 (€147.36 Mil) and increased from Dec. 2022 (€147.36 Mil) to Dec. 2023 (€154.67 Mil).


Kineta Additional Paid-In Capital Historical Data

The historical data trend for Kineta's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kineta Additional Paid-In Capital Chart

Kineta Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
44.98 67.38 147.36 154.67

Kineta Quarterly Data
Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 152.52 155.39 154.67 156.05 158.38

Kineta Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Kineta Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Kineta's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Kineta Business Description

Industry
Traded in Other Exchanges
Address
7683 SE 27th Street, Suite 481, Mercer Island, WA, USA, 98040
Kineta Inc is a clinical stage biotechnology company with a mission to develop next-generation immunotherapies that transform patients' lives. The company has leveraged its expertise in innate immunity and is focused on discovering and developing potentially differentiated immunotherapies that address the mechanisms of cancer immune resistance.

Kineta Headlines

No Headlines